Evaluation of adherence, persistence, and efficacy of treatment with Bempedoic acid in a real-life Italian population.
Patients under Bempedoic acid treatment
Age < 18 years o > 80 years
Patients who refuse to participate and to sign informed consent
The study population includes patients from Italy who have received Bempedoic acid as part of routine clinical management of their hyperlipidaemia, based on national reimbursement criteria at the time of enrollment.
Case-only
Other
Bempedoic acid
Drugfilm-coated tablets
Description of adherence to treatment with Bempedoic acid in a real-life Italian population
Adherence will be assessed in terms of Medical Possession Ratio (MPR), which is defined as the ratio between the treatment units dispensed during the treatment period and the duration of the treatment period itself.
Description of efficacy of treatment with Bempedoic acid in a real-life Italian population
Efficacy of treatment will be evaluated as a change in the LDL (deltaLDL) value from the start of treatment (percentage and absolute value).
Description of persistence to treatment with Bempedoic acid in a real-life Italian population
Persistence will be assessed in terms of therapeutic continuity from the start of treatment to enrollment.
Description of safety of treatment with Bempedoic acid in a real-life Italian population
Safety will be evaluated in terms of adverse reactions or intolerance to the drug.
Click on the lead sponsor to view all of their trials.
